title: Pre-clinical and Clinical Safety Studies of CMX-2043: a cytoprotective lipoic acid analogue for ischaemia-reperfusion injury.
abstract: CMX-2043 is an α-lipoic acid analogue targeted to reduction of cellular injury and organ damage due to ischaemia-reperfusion injury (IRI). It has been shown to be effective in a rat model of cardiac IRI. The studies here reported evaluate its safety and pharmacokinetic profile in preparation for human clinical studies in procedures associated with IRI. Safety and tolerability were tested in standard pre-clinical in vitro and animal models and in a Phase 1 human clinical trial. CMX-2043 did not bind to a wide range of receptors and specific targets at approximately 4 μg/mL (10 μM). It was not mutagenic by Ames assay, did not produce chromosome aberrations in Chinese hamster ovary (CHO) cells, and was negative for clastogenic potential. Toxicological studies in rats including both single and 14-day repeat intravenous doses and in dogs (single intravenous dose) with a 2-week recovery period were conducted. The NOAEL in rats and dogs was 30 and >10 mg/kg, respectively. No serious adverse events were reported in a placebo-controlled, sequential dose escalation Phase 1 clinical trial. The low toxicity in the pre-clinical studies and the absence of adverse events in the Phase 1 trial have supported investigation of CMX-2043 in a human efficacy trial.
authors.affiliation: Ischemix LLC, Maynard, MA, USA.
authors.forename: Steven A
authors.initials: SA
authors.lastname: Kates
authors.forename: Alan S
authors.initials: AS
authors.lastname: Lader
authors.forename: Ralph
authors.initials: R
authors.lastname: Casale
authors.forename: Reinier
authors.initials: R
authors.lastname: Beeuwkes
mesh_terms: D061605:Administration, Intravenous; D000293:Adolescent; D000328:Adult; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D004151:Dipeptides / Q000008:administration & dosage / Q000627:therapeutic use*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D009152:Mutagenicity Tests; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000188:drug therapy*; D008063:Thioctic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D004151:Dipeptides; C000602148:alpha-N-(1,2-dithiolane-3-pentanoyl)glutamylalanine; D008063:Thioctic Acid
references.citation: Intern Med. 2007;46(5):237-9
references.pmid: 17329919
references.citation: Diabetes Educ. 2007 Jan-Feb;33(1):111-7
references.pmid: 17272797
references.citation: Fed Regist. 2005 Oct 20;70(202):61133-4
references.pmid: 16237859
references.citation: Diabetologia. 1995 Dec;38(12):1425-33
references.pmid: 8786016
references.citation: J Clin Pharmacol. 2003 Nov;43(11):1257-67
references.pmid: 14551180
references.citation: Pharmacol Rep. 2005 Sep-Oct;57(5):570-7
references.pmid: 16227639
references.citation: Gen Pharmacol. 1997 Sep;29(3):315-31
references.pmid: 9378235
references.citation: Mult Scler. 2005 Apr;11(2):159-65
references.pmid: 15794388
references.citation: Cardiovasc Pathol. 2005 Jul-Aug;14(4):170-5
references.pmid: 16009313
references.citation: Metabolism. 1999 Apr;48(4):504-10
references.pmid: 10206446
references.citation: Expert Opin Pharmacother. 2012 Jun;13(8):1153-75
references.pmid: 22594845
references.citation: J Clin Pharmacol. 2005 Mar;45(3):313-28
references.pmid: 15703366
references.citation: Int J Cardiol. 2005 Apr 20;100(2):179-90
references.pmid: 15823623
references.citation: Bioorg Med Chem. 2014 Jan 1;22(1):505-12
references.pmid: 24316353
references.citation: Regul Toxicol Pharmacol. 2006 Oct;46(1):29-41
references.pmid: 16904799
references.citation: Regul Toxicol Pharmacol. 2006 Dec;46(3):193-201
references.pmid: 16899332
references.citation: Eur J Clin Invest. 2010 Feb;40(2):148-54
references.pmid: 20050880
references.citation: Free Radic Biol Med. 1999 Aug;27(3-4):309-14
references.pmid: 10468203
references.citation: Diabetes Care. 2006 Nov;29(11):2365-70
references.pmid: 17065669
references.citation: Free Radic Biol Med. 1995 Aug;19(2):227-50
references.pmid: 7649494
references.citation: Diabet Med. 2004 Feb;21(2):114-21
references.pmid: 14984445
references.citation: J Anim Physiol Anim Nutr (Berl). 2004 Apr;88(3-4):150-6
references.pmid: 15059240